Technical Analysis for KOD - Kodiak Sciences Inc

Grade Last Price % Change Price Change
C 102.75 5.64% 5.49
KOD closed up 5.64 percent on Friday, September 17, 2021, on 1.84 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical KOD trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Multiple of Ten Bullish Other 0.00%
Above Upper BB Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish 5.64%
Crossed Above 20 DMA Bullish 8.71%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 8.71%
Narrow Range Bar Range Contraction 8.71%
NR7 Range Contraction 8.71%
Older End-of-Day Signals for KOD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Kodiak Sciences Inc Description

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. The company's lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biological agent that is in Phase 1b clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy. Its preclinical stage product candidate include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases. The company's early research pipeline include KSI-601, a triplet inhibitor for dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was founded in 2009 and is headquartered in Palo Alto, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Inflammation Ophthalmology Macular Degeneration Related Macular Degeneration Vascular Diseases Retina Diabetic Retinopathy Wet Age Related Macular Degeneration Preclinical Stage Product Retinopathy Angiology Retinal Disease Angiogenesis Retinal Diseases Vascular Endothelial Growth Factor

Is KOD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 171.05
52 Week Low 49.6
Average Volume 236,969
200-Day Moving Average 111.38
50-Day Moving Average 90.66
20-Day Moving Average 95.51
10-Day Moving Average 96.20
Average True Range 4.78
ADX 22.69
+DI 33.20
-DI 15.35
Chandelier Exit (Long, 3 ATRs) 89.25
Chandelier Exit (Short, 3 ATRs) 100.85
Upper Bollinger Bands 101.06
Lower Bollinger Band 89.96
Percent B (%b) 1.15
BandWidth 11.62
MACD Line 2.15
MACD Signal Line 1.90
MACD Histogram 0.2472
Fundamentals Value
Market Cap 5.22 Billion
Num Shares 50.8 Million
EPS -1.50
Price-to-Earnings (P/E) Ratio -68.73
Price-to-Sales 0.00
Price-to-Book 22.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 113.51
Resistance 3 (R3) 112.49 107.90 111.71
Resistance 2 (R2) 107.90 105.16 108.40 111.11
Resistance 1 (R1) 105.32 103.47 106.61 106.34 110.52
Pivot Point 100.73 100.73 101.37 101.23 100.73
Support 1 (S1) 98.15 97.99 99.44 99.17 94.98
Support 2 (S2) 93.56 96.30 94.06 94.39
Support 3 (S3) 90.98 93.56 93.79
Support 4 (S4) 92.00